All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ1678 | Anti-ORAI3 (CBXO-0233) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Rat | CBXO-0233 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1679 | Anti-ORAI3 (CBXO-0234) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Rat | CBXO-0234 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1680 | Anti-ORAI3 (2H2G9) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Rat | 2H2G9 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1681 | Anti-ORAI3 (1B4F1) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Rat | 1B4F1 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ1682 | Anti-ORAI3 (CBXO-0071) h(41BB-CD3ζ) CAR, pCDCAR1 | Rat | CBXO-0071 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5102 | Anti-ORAI3 (CBXO-0233) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Rat | CBXO-0233 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5103 | Anti-ORAI3 (CBXO-0234) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Rat | CBXO-0234 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5104 | Anti-ORAI3 (2H2G9) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Rat | 2H2G9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5105 | Anti-ORAI3 (1B4F1) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Rat | 1B4F1 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5106 | Anti-ORAI3 (CBXO-0071) h(CD28-CD3ζ) CAR, pCDCAR1 | Rat | CBXO-0071 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION